Trial Outcomes & Findings for A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses (NCT NCT01583868)

NCT ID: NCT01583868

Last Updated: 2020-10-22

Results Overview

Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

216 participants

Primary outcome timeframe

At 1 week follow up

Results posted on

2020-10-22

Participant Flow

This was a randomized, bilateral, study, with a crossover at one week and a second crossover at two weeks. A total of 216 subjects (432 eyes) were enrolled in this study. Participants were randomized to receive either, the Test Lens C, Test Lens D and PureVision2 lenses, or the Test Lens C, Test Lens D and Air Optix Aqua lenses.

Participant milestones

Participant milestones
Measure
B&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then PureVision
B\&L RD2135-01 Lens C for one week then B\&L RD2135-01 Lens D for one week then PureVision2 for one week
B&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then Ciba Vis
B\&L RD2135-01 Lens C for one week then B\&L RD2135-01 Lens D for one week then Ciba Vision for one week
Overall Study
STARTED
108
108
Overall Study
COMPLETED
104
104
Overall Study
NOT COMPLETED
4
4

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
B&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then PureVision
n=105 Participants
B\&L RD2135-01 Lens C for one week then B\&L RD2135-01 Lens D for one week then PureVision2 for one week
B&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then Ciba Vis
n=105 Participants
B\&L RD2135-01 Lens C for one week then B\&L RD2135-01 Lens D for one week then Ciba Vision for one week
Total
n=210 Participants
Total of all reporting groups
Age, Continuous
31.3 years
STANDARD_DEVIATION 8.55 • n=5 Participants
31.8 years
STANDARD_DEVIATION 8.68 • n=7 Participants
31.5 years
STANDARD_DEVIATION 8.60 • n=5 Participants
Sex: Female, Male
Female
72 Participants
n=5 Participants
71 Participants
n=7 Participants
143 Participants
n=5 Participants
Sex: Female, Male
Male
33 Participants
n=5 Participants
34 Participants
n=7 Participants
67 Participants
n=5 Participants

PRIMARY outcome

Timeframe: At 1 week follow up

Population: There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.

Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Outcome measures

Outcome measures
Measure
B&L RD2135-01 Lens C
n=424 eyes
Investigational Silicone hydrogel soft contact lens B\&L RD2135-01 lens C: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
B&L RD2135-01 Lens D
n=424 eyes
Investigational Silicone hydrogel soft contact lens B\&L RD2135-01 lens D: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
PureVision2
n=212 eyes
Bausch \& Lomb High definition soft contact lenses PureVision2: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
Ciba Vision Air Optix Aqua
n=212 eyes
Ciba Vision Air Optix Aqua soft contact lens Air Optix Aqua: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
Visual Acuity
-0.089 logMAR
Standard Deviation 0.078
-0.087 logMAR
Standard Deviation 0.079
-0.086 logMAR
Standard Deviation 0.077
-0.086 logMAR
Standard Deviation 0.082

SECONDARY outcome

Timeframe: At 1 Week follow up

Population: There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.

Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints. Symptoms/complaints were recorded for each eye based on the participant's experience with their study lenses worn for that respective treatment period. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, Lens cleanness, Dryness at end of day, and Overall impression.

Outcome measures

Outcome measures
Measure
B&L RD2135-01 Lens C
n=212 Participants
Investigational Silicone hydrogel soft contact lens B\&L RD2135-01 lens C: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
B&L RD2135-01 Lens D
n=424 eyes
Investigational Silicone hydrogel soft contact lens B\&L RD2135-01 lens D: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
PureVision2
n=212 eyes
Bausch \& Lomb High definition soft contact lenses PureVision2: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
Ciba Vision Air Optix Aqua
n=212 eyes
Ciba Vision Air Optix Aqua soft contact lens Air Optix Aqua: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.
Symptoms and Complaints
Vision in low light
91.0 score on a scale
Standard Deviation 11.9
89.9 score on a scale
Standard Deviation 13.4
87.3 score on a scale
Standard Deviation 13.8
91.4 score on a scale
Standard Deviation 12.5
Symptoms and Complaints
Burning/stinging upon insertion
91.3 score on a scale
Standard Deviation 13.1
91.3 score on a scale
Standard Deviation 12.4
83.1 score on a scale
Standard Deviation 21.4
92.6 score on a scale
Standard Deviation 9.9
Symptoms and Complaints
Comfort upon insertion
89.6 score on a scale
Standard Deviation 14.5
88.2 score on a scale
Standard Deviation 15.6
78.7 score on a scale
Standard Deviation 15.6
89.6 score on a scale
Standard Deviation 12.0
Symptoms and Complaints
Overall comfort
88.0 score on a scale
Standard Deviation 14.6
85.7 score on a scale
Standard Deviation 16.9
78.4 score on a scale
Standard Deviation 20.4
86.6 score on a scale
Standard Deviation 15.8
Symptoms and Complaints
Ease of handling/insertion
89.5 score on a scale
Standard Deviation 16.6
88.6 score on a scale
Standard Deviation 17.3
85.0 score on a scale
Standard Deviation 20.4
89.0 score on a scale
Standard Deviation 15.3
Symptoms and Complaints
Dryness
84.4 score on a scale
Standard Deviation 16.1
81.9 score on a scale
Standard Deviation 18.1
77.0 score on a scale
Standard Deviation 21.6
84.4 score on a scale
Standard Deviation 17.3
Symptoms and Complaints
Vision upon insertion
93.4 score on a scale
Standard Deviation 9.6
91.5 score on a scale
Standard Deviation 13.3
87.0 score on a scale
Standard Deviation 17.5
93.1 score on a scale
Standard Deviation 9.6
Symptoms and Complaints
Vision
92.3 score on a scale
Standard Deviation 11.4
91.9 score on a scale
Standard Deviation 13.1
88.1 score on a scale
Standard Deviation 14.6
93.5 score on a scale
Standard Deviation 10.3
Symptoms and Complaints
Lens cleannes upon removal
89.9 score on a scale
Standard Deviation 12.2
89.3 score on a scale
Standard Deviation 12.9
86.3 score on a scale
Standard Deviation 17.2
90.9 score on a scale
Standard Deviation 9.7
Symptoms and Complaints
Lens cleanness
91.8 score on a scale
Standard Deviation 10.6
91.2 score on a scale
Standard Deviation 11.7
86.6 score on a scale
Standard Deviation 17.0
92.5 score on a scale
Standard Deviation 9.1
Symptoms and Complaints
Dryness at end of day
82.4 score on a scale
Standard Deviation 17.7
80.3 score on a scale
Standard Deviation 19.3
75.5 score on a scale
Standard Deviation 21.7
82.4 score on a scale
Standard Deviation 17.3
Symptoms and Complaints
Overall impression
84.5 score on a scale
Standard Deviation 17.0
82.2 score on a scale
Standard Deviation 19.0
73.7 score on a scale
Standard Deviation 24.6
83.9 score on a scale
Standard Deviation 18.3
Symptoms and Complaints
Comfort at end of day
81.2 score on a scale
Standard Deviation 18.9
79.3 score on a scale
Standard Deviation 20.2
72.0 score on a scale
Standard Deviation 22.9
79.7 score on a scale
Standard Deviation 19.7
Symptoms and Complaints
Ease of handling/removal
91.1 score on a scale
Standard Deviation 14.3
91.0 score on a scale
Standard Deviation 13.6
89.4 score on a scale
Standard Deviation 15.6
89.4 score on a scale
Standard Deviation 15.5
Symptoms and Complaints
Itchiness
90.6 score on a scale
Standard Deviation 12.9
89.6 score on a scale
Standard Deviation 15.9
87.4 score on a scale
Standard Deviation 17.0
88.5 score on a scale
Standard Deviation 17.3
Symptoms and Complaints
Redness
92.4 score on a scale
Standard Deviation 11.7
91.6 score on a scale
Standard Deviation 13.1
90.6 score on a scale
Standard Deviation 14.0
91.2 score on a scale
Standard Deviation 12.5
Symptoms and Complaints
Lens cleanness upon insertion
93.1 score on a scale
Standard Deviation 10.9
92.8 score on a scale
Standard Deviation 11.4
89.7 score on a scale
Standard Deviation 14.6
94.4 score on a scale
Standard Deviation 7.7

Adverse Events

B&L RD2135-01 Lens C

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

B&L RD2135-01 Lens D

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PureVision2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Ciba Vision Air Optix Aqua

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Study Director

Bausch Health

Results disclosure agreements

  • Principal investigator is a sponsor employee Contact sponsor directly for details.
  • Publication restrictions are in place

Restriction type: OTHER